Trigen and ProCorde Merge to Create Europe’s...

Complete pipeline of novel, competitive, clinical-stage products addressing major in-hospital and out-patient thrombosis markets — Extensive portfolio of pre-clinical and discovery-stage programmes and platforms targeting cardiovascular diseases — Complementary expertise with resulting competences in discovery, development and commercialisation of small molecules and protein therapeutics —...